Occurrence of theJAK2 V617Fmutation in patients with peripheral arterial disease-Reference-Cited by-同舟云学术

Occurrence of theJAK2 V617Fmutation in patients with peripheral arterial disease

Published:2014-11-20 Issue:1 Volume:90 Page:E17-E21
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Muendlein Axel¹,Kinz Elena¹²,Gasser Klaus¹²³,Leiherer Andreas¹²⁴,Rein Philipp¹³,Saely Christoph H.¹²³,Grallert Harald⁵,Peters Annette⁵⁶⁷,Fraunberger Peter⁴,Drexel Heinz¹²³⁸,Lang Alois H.³

Affiliation:

1. Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT); Feldkirch Austria

2. Private University of the Principality of Liechtenstein; Triesen Liechtenstein

3. Department of Medicine and Cardiology; Academic Teaching Hospital Feldkirch; Feldkirch Austria

4. Medical Central Laboratories; Feldkirch Austria

5. Research Unit of Molecular Epidemiology, Helmholtz Zentrum Muenchen; German Research Center for Environmental Health; Neuherberg Germany

6. Institute of Epidemiology II, Helmholtz Zentrum Muenchen; German Research Center for Environmental Health; Neuherberg Germany

7. German Research Center for Cardiovascular Disease (DZHK-Munich partner site); Munich Germany

8. Drexel College University of Medicine; Philadelphia Pennsylvania

Funder

Land Vorarlberg

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23874/fullpdf

Reference56 articles.

1. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease [(PAD) lower extremity, renal, mesenteric, and abdominal aortic]: A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation;Hirsch;Circulation,2006

2. Long-term prognosis of patients with peripheral arterial disease: A comparison in patients with coronary artery disease;Welten;J Am Coll Cardiol,2008

3. Inflammation in peripheral artery disease;Brevetti;Circulation,2010

4. Inflammation and peripheral arterial disease: The value of circulating biomarkers (Review);Signorelli;Int J Mol Med,2014

5. Immune and inflammatory mechanisms of atherosclerosis (*);Galkina;Annu Rev Immunol,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatic Variants Acquired Later in Life Associated with Thoracic Aortic Aneurysms: JAK2 V617F;Genes;2024-07-05

2. JAK2V617Fmutation is highly prevalent in patients with ischemic stroke: a case-control study;Blood Advances;2023-09-29

3. Unveiling the Genetic Footprint: Exploring Somatic Mutations in Peripheral Arterial Disease Progression;Biomedicines;2023-08-17

4. Neglected Mendelian causes of stroke in adult Chinese patients who had an ischaemic stroke or transient ischaemic attack;Stroke and Vascular Neurology;2023-07-26

5. Atrial fibrillation and peripheral arterial disease define MPN patients with very high risk of thrombosis;Thrombosis Research;2023-06